Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer

Urology

Volumn 77, Issue 2, 2011, Pages 396-401

  Kattan, Michael W ^a   Yu, Changhong ^a   Salomon, Laurent ^b   Vora, Kinjal ^c   Touijer, Karim ^c   Guillonneau, Bertrand ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HENRI MONDOR HOSPITAL   (France)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; AGED; ANTIGEN BLOOD LEVEL; ARTICLE; CALIBRATION; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; EXTERNAL VALIDITY; FOLLOW UP; GLEASON SCORE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NOMOGRAM; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; TREATMENT FAILURE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PREOPERATIVE CARE; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 79551583554     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.05.013     Document Type: Article

References (23)

1. G.W. Chodak, R.A. Thisted, and G.S. Gerber Results of conservative management of clinically localized prostate cancer N Engl J Med 330 1994 242 248
2. P.C. Albertson, D.G. Fryback, and B.E. Storer Long-term survival among men with conservatively treated localized prostate cancer JAMA 274 1995 626 631
3. G.E. Hanks, W.R. Lee, and T.E. Schultheiss Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation J Urol 154 1995 456 459
4. M.A. Bagshaw, R.S. Cox, and S.L. Hancock Control of prostate cancer with radiotherapy: long-term results J Urol 152 1994 1781 1785
5. M. Ohori, T.M. Wheeler, and M.W. Kattan Prognostic significance of positive surgical margins in radical prostatectomy specimens J Urol 154 1995 1818 1824
6. G.S. Gerber, R.A. Thisted, and P.T. Scardino Results of radical prostatectomy in men with clinically localized prostate cancer JAMA 276 1996 615 619
7. C.R. Pound, A.W. Partin, and J.I. Epstein Prostate-specific antigen after anatomic radical retropubic prostatectomy Urol Clin North Am 24 1997 395 406
8. J.G. Trapasso, J.B. deKernion, and R.B. Smith The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy J Urol 152 1994 1821 1825
9. H. Ragde, J.C. Blasko, and P.D. Grimm Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma Cancer 80 1997 442 453
10. M. Ohori, T.M. Wheeler, and P.T. Scardino The new American Joint Committee on Cancer and International Union Against Cancer TNM Classification of prostate cancer: clinicopathologic correlations Cancer 74 1994 104 114
11. S. Van Buuren, and C.G.M. Groothuis-Oudshoorn Multivariate Imputation by Chained Equations: MICE V1.0 User's Manual 2000 TNO Quality of Life Leiden, The Netherlands
12. F.E. Harrell, K.L. Lee, and D.B. Mark Multivariable prognostic modelsissues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stats Med 15 1996 361 387
13. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
14. F.E. Harrell Design: S-PLUS function for biostatistical/epidemiologic modeling, testing, estimation, validation, graphics, prediction, and typesetting by storing enhanced model design attributes in the fit www.lib.stat.cmu.edu 1994 Accessed July 6, 1996
15. B. Efron, and R.J. Tibshirani An Introduction to the Bootstrap 1993 Chapman and Hall New York
16. K. Shariat, P. Karakiewicz, and V. Margulis Inventory of prostate cancer predictive tools Curr Opin Urol 18 2008 279 296 (Pubitemid 351489379)
17. C. Nguyen, and M.W. Kattan Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling Cancer 115 suppl 2009 3039 3045
18. M. Specht, M. Kattan, and M. Gonen Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram Ann Surg Oncol 12 2005 654 659
19. P.L. Ross, C. Gerigk, and M. Gonen Comparisons of nomograms and urologists'' predictions in prostate cancer Semin Urol Oncol 20 2002 82 88
20. R. Ross, and P. Kantoff Predicting outcomes in prostate cancer: how many more nomograms do we need? J Clin Oncol 25 2007 3563 3564
21. A. Stephenson, P. Scardino, and J. Eastham Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 2006 715 717
22. M.W. Kattan, A. Vickers, and C. Yu Preoperative and postoperative nomograms incorporating surgeon experience for localized prostate cancer Cancer 115 2009 1005 1010
23. M.W. Kattan Comparative effectiveness: a table of expected benefits and harms Med Decis Mak 29 2009 NP3 NP5